Home Compare DXCM vs LLY
Stock Comparison · Structural lead, mixed market

DexCom vs Eli Lilly and Company: Which Stock Looks Stronger in 2026?

Eli Lilly and Company holds the cleaner structural position, with the lead spread across growth and profitability. The remaining gap is narrow enough that the comparison remains open to different readings. The market setup is mixed, without a decisive signal in either direction. The market is not adding a decisive signal either way — the structural read carries the weight.

The comparison is based on similar long-term financial trajectories, not sector labels. Both peer scores are relative to the S&P 500 universe, making them directly comparable.

Updated 2026-08-16

The lead is spread across growth and profitability, rather than sitting in one isolated gap. The overall score gap is 8 points in favour of Eli Lilly and Company.

Trajectory Similarity
0.63
Moderately similar
Peer-set rank: #40
within DexCom, Inc.'s functional peer set

These two companies are linked by measured long-term financial trajectory similarity within the selected peer universe.

This level of similarity points to a meaningful structural match, though not a tight one.

Most of the shared profile comes through capital structure and margin consistency.

Similarity drivers
capital structuremargin consistency
What reduces the match
recent revenue growth
How to read the score
0.85–1.00 · Very similar0.70–0.84 · Similar0.55–0.69 · Moderately similarbelow 0.55 · Loose match
Peer-Relative Score
DXCM
DexCom, Inc.
58
Peer-Score
Signal qualitylow
Peer basis: S&P 500
vs
LLY
Eli Lilly and Company
66
Peer-Score
Signal qualityHigh
Peer basis: S&P 500

Scores reflect position relative to comparable companies with similar long-term financial trajectories.

The largest gaps do not all point in the same direction.

Dimension spread: DXCM vs LLY Profitability 84 100 Stability 26 34 Valuation 54 46 Growth 54 75 DXCM LLY
Gap Ranking
#1 Growth +21
#2 Profitability +16
#3 Valuation +8
#4 Stability +8
Price Setup

Left means cheaper relative valuation. Higher means stronger structure.

Price setup map for DXCM and LLY Stronger + cheaper Stronger + richer Weaker + cheaper Weaker + richer DXCMLLY Relative valuation Structural strength

The setup is mixed: neither company clearly combines the stronger profile with the more supportive price setup.

Valuation position uses peer-relative PE percentile (idx_pct_pe) where available.

Entry today — historical context

Where DXCM and LLY each sit in their own 5-year price and valuation history.

BASED ON 5-YEAR HISTORY DXCM Neutral · below norm 0th 50th 100th 47 pct gap LLY Elevated · below norm 0th 50th 100th 51st 98th
Today DXCM sits in the upper-middle of its own 5-year history (51st percentile), while LLY sits higher in its own history (98th). Within each stock's own 5-year context, DXCM is at a historically more favourable entry position than LLY. This reflects entry timing, not which company is structurally stronger — peer-relative analysis is a separate question addressed above.

Describes historical entry positioning only. Descriptive — not investment advice.

Relative Position vs Comparable Companies
Growth
Both look solid on growth, though Eli Lilly and Company still holds the stronger peer position.
Profitability
The same pattern holds on profitability: both sit in the stronger range, with DexCom, Inc. still higher.
Growth — Dominant Gap
DXCM
54
LLY
75
Gap+21in favour of LLY

Revenue growth reinforces the category-level growth lead.

What keeps the gap from being one-sided

Absolute pricing still looks more supportive for DexCom, with a trailing P/E that is 3.6 turns lower there.

What this means for the comparison

The lead is built on both growth and profitability, making it broader than a single-dimension result.

Explore full peer positioning in AssetNext

Break down the DXCM vs LLY comparison across all dimensions with the full interactive tool.

Explore full breakdown →
Similar growth-and-profitability comparisons

Explore how DXCM and LLY each compare against other companies in their peer groups.

Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.

How AssetNext Peer Scores Work

AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.

Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.

Because scores are peer-relative, the same company can have slightly different scores in different index universes. On comparison pages, both companies are shown within their shared peer universe wherever possible — so the scores are directly comparable. The peer basis is stated on each score card.

Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.